Roman Skowroński - Concepedia

Author

Roman Skowroński

Also Known As

R J Skowronski, R SKOWRONSKI, R Skowronski, R Skowroński, R. J. Skowronski, R. Skowronski, R. Skowroñski, R. Skowroński, ROMAN SKOWRONSKI, Roman J Skowronski

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Stanford University Jazz Pharmaceuticals (United States)Cleveland Clinic Albert Einstein College of Medicine University of South Carolina

About

Roman Skowroński is an author at Stanford University specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.8K
2	Health Sciences	7	7	349
3	Engineering	1	1	82
4	Natural Sciences	1	1	41
5	Anesthesia	1	1	13

Roman Skowroński

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. D.M. Peehl, Roman Skowroński, Gordon Leung, PubMed Urology1,25-Dihydroxyvitamin D3Vitamin D ReceptorsMedicineGrowth Inhibition	1994	478
Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Roman Skowroński, D M Peehl, David Feldman Endocrinology Tumor BiologyUrologyOncogenic AgentMedicinePharmacology	1993	473
Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Roman Skowroński, D M Peehl, David Feldman Endocrinology Tumor BiologyUrologyChemoprevention StrategyVitamin D31,25-Dihydroxyvitamin D3	1995	203
Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus. Y D Chen, S Swami, Roman Skowroński, The Journal of Clinical Endocrinology & Metabolism NutritionNoninsulin-dependent Diabetes MellitusObesityMetabolic SyndromeBody Composition	1993	143
Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines Roman Skowroński Endocrinology UrologyOncologyOncogenic AgentMedicineReceptor (Biochemistry)	1993	129
Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control. Gerald M. Reaven, P. Johnston, C.B. Hollenbeck, The Journal of Clinical Endocrinology & Metabolism Metformin-sulfonylurea TreatmentHigh DensityMetabolic SyndromeInsulin DeliveryHealth Sciences	1992	86
An in vivo/in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer Jeremy C. Wright, Sally Tao Leonard, Cynthia L. Stevenson, Journal of Controlled Release Tissue EngineeringLeuprolide Osmotic ImplantUrologyEngineeringVivo/in Vitro Comparison	2001	82
Effects of Nandrolone Decanoate Therapy in Borderline Hypogonadal Men With HIV-Associated Weight Loss Alison Strawford, Teresa Barbieri, Richard A. Neese, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology	1999	76
Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy Richard Bogan, Michael J. Thorpy, Yves Dauvilliers, SLEEP	2020	70
Characterization of an Estrogen-Binding Protein in the Yeast<i>Candida albicans</i>* Roman Skowroński, David Feldman Endocrinology	1989	65

Page 1